LONDON BROKER RATINGS: Morgan Stanley cuts Mondi; BofA cuts Ashtead
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 508.00p on 03-02-2026 at 19:05:07 |
|---|---|
| Change | 7.00p 1.4% |
| Buy | 510.00p |
| Sell | 509.00p |
| Last Trade: | Sell 1,057.00 at 508.00p |
| Day's Volume: | 822,226 |
| Last Close: | 508.00p |
| Open: | 501.00p |
| ISIN: | GB00B45C9X44 |
| Day's Range | 501.00p - 513.00p |
| 52wk Range: | 297.50p - 614.00p |
| Market Capitalisation: | £1.37b |
| VWAP: | 507.2451p |
| Shares in Issue: | 268.97m |
Chemring (CHG) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 1,057 | 508.00p | SI Trade |
16:35:22 - 03-Feb-26 |
| Sell* | 235,316 | 508.00p | Uncrossing Trade |
16:35:22 - 03-Feb-26 |
| Buy* | 68 | 510.00p | Automatic Execution |
16:28:35 - 03-Feb-26 |
| Sell* | 436 | 509.00p | Automatic Execution |
16:28:24 - 03-Feb-26 |
| Sell* | 361 | 509.00p | Automatic Execution |
16:28:20 - 03-Feb-26 |
| Sell* | 436 | 509.00p | Automatic Execution |
16:28:19 - 03-Feb-26 |
| Sell* | 436 | 509.00p | Automatic Execution |
16:28:19 - 03-Feb-26 |
| Sell* | 154 | 509.00p | Automatic Execution |
16:28:18 - 03-Feb-26 |
| Unknown* | 74 | 509.00p | SI Trade |
16:28:17 - 03-Feb-26 |
| Sell* | 509 | 509.00p | Automatic Execution |
16:28:17 - 03-Feb-26 |
Chemring (CHG) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Feb 2026 7:00 am | RNS | Total Voting Rights |
| 23rd Jan 2026 4:41 pm | RNS | Director/PDMR Shareholding |
| 12th Jan 2026 1:35 pm | RNS | Notice of AGM |
| 2nd Jan 2026 10:29 am | RNS | Total Voting Rights |
| 19th Dec 2025 11:53 am | RNS | Holding(s) in Company |
| 19th Dec 2025 11:53 am | RNS | Holding(s) in Company |
| 18th Dec 2025 7:00 am | RNS | Block listing Interim Review |
| 16th Dec 2025 7:00 am | RNS | Director/PDMR Shareholding |
| 16th Dec 2025 7:00 am | RNS | Director/PDMR Shareholding |
| 16th Dec 2025 7:00 am | RNS | Director/PDMR Shareholding |